PROJECT 11
Hybrid 18F-sodiumfluoride (NaF) positron emission tomography (PET)/magnetic resonance imaging (MRI) for non-invasive identification of microcalcifications as marker of arterial plaque vulnerability in human carotid- and coronary arteries.
The objective of INTRICARE is to train a new generation of scientist that will be excellently skilled to expedite our understanding of vulnerable plaque formation, with a particular focus on microcalcification, and to develop innovative solutions for the early prevention, diagnosis, and treatment of atherosclerosis.
The duration of the program is 48 months, consisting of 15 ESR projects of 36 months each. The INTRICARE programme will start as from March 1, 2017. Interested applicants are invited to apply via the vacancy form on this website
Hybrid 18F-sodiumfluoride (NaF) positron emission tomography (PET)/magnetic resonance imaging (MRI) for non-invasive identification of microcalcifications as marker of arterial plaque vulnerability in human carotid- and coronary arteries.
Innovative platforms to generate fetuin-A based imaging agents for diagnosis and treatment of microcalcification.
Targeting Extracellular Vesicles for diagnosis and treatment of vascular calcification.
Role of AT2 receptor in intimal calcification.
Modulating Vitamin K-dependent proteins targeting Vascular calcification.